Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 21:10:e53551.
doi: 10.2196/53551.

Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Europe: Longitudinal Trend Analysis

Affiliations

Updated Surveillance Metrics and History of the COVID-19 Pandemic (2020-2023) in Europe: Longitudinal Trend Analysis

Alexander L Lundberg et al. JMIR Public Health Surveill. .

Abstract

Background: In this study, we built upon our initial research published in 2020 by incorporating an additional 2 years of data for Europe. We assessed whether COVID-19 had shifted from the pandemic to endemic phase in the region when the World Health Organization (WHO) declared the end of the public health emergency of international concern on May 5, 2023.

Objective: We first aimed to measure whether there was an expansion or contraction in the pandemic in Europe at the time of the WHO declaration. Second, we used dynamic and genomic surveillance methods to describe the history of the pandemic in the region and situate the window of the WHO declaration within the broader history. Third, we provided the historical context for the course of the pandemic in Europe in terms of policy and disease burden at the country and region levels.

Methods: In addition to the updates of traditional surveillance data and dynamic panel estimates from the original study, this study used data on sequenced SARS-CoV-2 variants from the Global Initiative on Sharing All Influenza Data to identify the appearance and duration of variants of concern. We used Nextclade nomenclature to collect clade designations from sequences and Pangolin nomenclature for lineage designations of SARS-CoV-2. Finally, we conducted a 1-tailed t test for whether regional weekly speed was greater than an outbreak threshold of 10. We ran the test iteratively with 6 months of data across the sample period.

Results: Speed for the region had remained below the outbreak threshold for 4 months by the time of the WHO declaration. Acceleration and jerk were also low and stable. While the 1-day and 7-day persistence coefficients remained statistically significant, the coefficients were moderate in magnitude (0.404 and 0.547, respectively; P<.001 for both). The shift parameters for the 2 weeks around the WHO declaration were small and insignificant, suggesting little change in the clustering effect of cases on future cases at the time. From December 2021 onward, Omicron was the predominant variant of concern in sequenced viral samples. The rolling t test of speed equal to 10 became insignificant for the first time in April 2023.

Conclusions: While COVID-19 continues to circulate in Europe, the rate of transmission remained below the threshold of an outbreak for 4 months ahead of the WHO declaration. The region had previously been in a nearly continuous state of outbreak. The more recent trend suggested that COVID-19 was endemic in the region and no longer reached the threshold of the pandemic definition. However, several countries remained in a state of outbreak, and the conclusion that COVID-19 was no longer a pandemic in Europe at the time is unclear.

Keywords: Albania; Andorra; Arellano-Bond estimators; Austria; Belarus; Belgium; Bosnia and Herzegovina; Bulgaria; COVID-19; Croatia; Denmark; Estonia; Europe; Finland; France; Germany; Greece; Greenland; Hungary; Iceland; Ireland; Italy; Latvia; Liechtenstein; Lithuania; Luxembourg; Moldova; Monaco; Montenegro; Norway; Poland; Portugal; Romania; San Marino; Serbia; Slovakia; Slovenia; Spain; Sweden; Switzerland; Ukraine; history of the pandemic; method of the moments; the Czech Republic; the Isle of Man; the Netherlands; the United Kingdom; the Vatican City.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Novel surveillance metrics (speed, acceleration, jerk, and 7-day persistence) for COVID-19 transmissions in Europe from August 2020 to May 2023.
Figure 2
Figure 2
Variants of concern (VOCs) as a proportion of all sequenced SARS-CoV-2 specimens from April 2020 to May 2023 in Europe.
Figure 3
Figure 3
P values from t tests of weekly COVID-19 transmissions per 100,000 people equal to 10 over a rolling, 6-month window in Europe.
Figure 4
Figure 4
Timeline of the COVID-19 pandemic in Europe. EU: European Union; VOC: variants of concern; WHO: World Health Organization.

Similar articles

Cited by

References

    1. Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie. 2020 Dec;179:85–100. doi: 10.1016/j.biochi.2020.09.018.S0300-9084(20)30224-8 - DOI - PMC - PubMed
    1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses. 2021 Jan 29;13(2):202. doi: 10.3390/v13020202.v13020202 - DOI - PMC - PubMed
    1. Chilamakuri R, Agarwal S. COVID-19: characteristics and therapeutics. Cells. 2021 Jan 21;10(2):206. doi: 10.3390/cells10020206.cells10020206 - DOI - PMC - PubMed
    1. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar 06;19(3):141–54. doi: 10.1038/s41579-020-00459-7.10.1038/s41579-020-00459-7 - DOI - PMC - PubMed
    1. Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. The novel coronavirus disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies. Virology. 2020 Dec;551:1–9. doi: 10.1016/j.virol.2020.08.011.S0042-6822(20)30172-0 - DOI - PMC - PubMed

Publication types